Teva's Gemzar ANDAs Infringe Lilly Patent: Judge
A federal judge has ruled that Teva Pharmaceuticals USA Inc.'s abbreviated new drug applications for Gemzar infringe an Eli Lilly & Co. patent, enjoining the generics maker from introducing its own...To view the full article, register now.
Already a subscriber? Click here to view full article